WHO ICTRP trial

Antiplatelet therapy after successful percutaneous coronary intervention for…

CTIS2023-508148-23-01 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2023-508148-23-01
Public title Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy
Scientific title Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy - Etude DAPT-CTO
Primary sponsor Assistance Publique Hopitaux De Marseille
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No
Countries France
Conditions chronically occluded coronary artery;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Interventions Product Name: CLOPIDOGREL, Product Code:SUB13395MIG, Pharmaceutical Form: FILM-COATED TABLET, Other descriptive name: , Strength: , Product Name: CLOPIDOGREL, Product Code:SUB13395MIG, Pharmaceutical Form: FILM-COATED TABLET, Other…
Registration date Jul 2, 2024
Target size 660
Secondary IDs RCAPHM23_0327_
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations